Toll-like Receptors and Diabetes Complications: Recent Advances

Author(s): Sandra Rosa Ramirez, Mohan Ravi Krishna Dasu

Journal Name: Current Diabetes Reviews

Volume 8 , Issue 6 , 2012

Become EABM
Become Reviewer
Call for Editor


Diabetes mellitus (DM) is a disease with constellation of metabolic aberrations resulting in debilitating complications. The prevalence of DM worldwide was 2.8% (171 million people) in 2000 and estimated to be at 4.4% (366 million people) in 2030. DM is a major risk factor for heart, kidney diseases, and lower limb amputations. Emerging in vitro and in vivo data suggest that systemic inflammation plays a role in the pathogenesis of DM complications via innate immune receptors. Toll-like receptors (TLRs) are key innate immune receptors that mediate the inflammatory responses in DM. There are no reviews that collectively summarize and examine the detrimental role of TLRs in the manifestation of DM complications namely heart disease, nephropathy, neuropathy, and wound healing. Thus, in this review, we will provide summaries of the TLR expression and activation and elucidate their role in propagating inflammation seen in DM complications.

Keywords: Diabetes mellitus, TLR2, TLR4, Inflammation, atherosclerosis, nephropathy, neuropathy, wound healing, manifestation, multifactorial disease, puberty.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 09 October, 2012
Page: [480 - 488]
Pages: 9
DOI: 10.2174/157339912803529887
Price: $65

Article Metrics

PDF: 15